[1]
Kumar, A. and Prakash, A.S. 2019. Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on therapy. Journal of the ASEAN Federation of Endocrine Societies. 34, 1 (Jul. 2019), 87. DOI:https://doi.org/10.15605/jafes.034.01.13.